Ex vivo MRI of axillary lymph nodes in breast cancer

European Journal of Radiology

Volumn 69, Issue 1, 2009, Pages 59-66

  Luciani, Alain ^a   Pigneur, Frederic ^a   Ghozali, Faridah ^a   Dao, Thu Ha ^a   Cunin, Patrick ^a   Meyblum, Evelyne ^a   De Baecque Fontaine, Cecile ^a   Alamdari, Ali ^a   Maison, Patrick ^a   Deux, Jean François ^a   Lagrange, Jean Léon ^a   Lantieri, Laurent ^a   Rahmouni, Alain ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Axillary lymph Nodes; Breast cancer; MR pathological correlations; MRI

Indexed keywords

AXILLARY LYMPH NODES; BREAST CANCER; CORTICAL THICKNESSES; EX-VIVO; INVERSION RECOVERIES; LYMPH NODES; MR-PATHOLOGICAL CORRELATIONS; MRI; PEARSON COEFFICIENTS; PREDICTIVE VALUES; PROSPECTIVE STUDIES; QUANTITATIVE VARIABLES; WHITNEY;

CORRELATION METHODS; PATHOLOGY;

BODY FLUIDS;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; DEVICE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 58149512847     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2008.07.040     Document Type: Article

References (31)

1. Kuhl C.K., Schmutzler R.K., Leutner C.C., et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 215 (2000) 267-279
2. Kuhl C.K. Current status of breast MR imaging. Part 2. Clinical applications. Radiology 244 (2007) 672-691
3. Kuhl C.K. MRI of breast tumors. Eur Radiol 10 (2000) 46-58
4. Kuhl C., Kuhn W., Braun M., and Schild H. Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back?. Breast 16 Suppl. 2 (2007) 34-44
5. Morris E.A. Diagnostic breast MR imaging: current status and future directions. Radiol Clin North Am 45 (2007) 863-880 vii
6. Sardanelli F., Podo F., D'Agnolo G., et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 242 (2007) 698-715
7. Pediconi F., Catalano C., Roselli A., et al. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology 243 (2007) 670-680
8. Lord S.J., Lei W., Craft P., et al. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 43 (2007) 1905-1917
9. Riedl C.C., Ponhold L., Flory D., et al. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clin Cancer Res 13 (2007) 6144-6152
10. Dao T.H., Rahmouni A., Servois V., and Nguyen-Tan T. MR imaging of the breast in the follow-up evaluation of conservative nonoperatively treated breast cancer. Magn Reson Imaging Clin N Am 2 (1994) 605-622
11. Dao T.H., Rahmouni A., Campana F., Laurent M., Asselain B., and Fourquet A. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 187 (1993) 751-755
12. Stets C., Brandt S., Wallis F., Buchmann J., Gilbert F.J., and Heywang-Kobrunner S.H. Axillary lymph node metastases: a statistical analysis of various parameters in MRI with USPIO. J Magn Reson Imaging 16 (2002) 60-68
13. Murray A.D., Staff R.T., Redpath T.W., et al. Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes. Br J Radiol 75 (2002) 220-228
14. Carter C.L., Allen C., and Henson D.E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63 (1989) 181-187
15. Silverstein M.J., Skinner K.A., and Lomis T.J. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 25 (2001) 767-772
16. Moore M.P., and Kinne D.W. Axillary lymphadenectomy: a diagnostic and therapeutic procedure. J Surg Oncol 66 (1997) 2-6
17. Hsiang D.J., Yamamoto M., Mehta R.S., et al. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab. Arch Surg 142 (2007) 855-861 [discussion 851-60]
18. Luciani A., Dao T.H., Lapeyre M., et al. Simultaneous bilateral breast and high-resolution axillary MRI of patients with breast cancer: preliminary results. Am J Roentgenol 182 (2004) 1059-1067
19. Luciani A., Itti E., Rahmouni A., Meignan M., and Clement O. Lymph node imaging: basic principles. Eur J Radiol (2006)
20. Memarsadeghi M., Riedl C.C., Kaneider A., et al. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging. Radiology 241 (2006) 367-377
21. Kuehn T., Bembenek A., Decker T., et al. A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance. Cancer 103 (2005) 451-461
22. Lyman G.H., Giuliano A.E., Somerfield M.R., et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23 (2005) 7703-7720
23. Uematsu T., Sano M., and Homma K. In vitro high-resolution helical CT of small axillary lymph nodes in patients with breast cancer: correlation of CT and histology. Am J Roentgenol 176 (2001) 1069-1074
24. Harada T., Tanigawa N., Matsuki M., Nohara T., and Narabayashi I. Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur J Radiol 63 (2007) 401-407
25. Cermik T.F., Mavi A., Basu S., and Alavi A. Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer. Eur J Nucl Med Mol Imaging (2007)
26. Stadnik T.W., Everaert H., Makkat S., Sacre R., Lamote J., and Bourgain C. Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging-initial findings. Eur Radiol 16 (2006) 2153-2160
27. Kumar R., Zhuang H., Schnall M., et al. FDG PET positive lymph nodes are highly predictive of metastasis in breast cancer. Nucl Med Commun 27 (2006) 231-236
28. Crippa F., Gerali A., Alessi A., Agresti R., and Bombardieri E. FDG-PET for axillary lymph node staging in primary breast cancer. Eur J Nucl Med Mol Imaging 31 Suppl 1 (2004) S97-S102
29. Aarsvold J.N., and Alazraki N.P. Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med 35 (2005) 116-128
30. Cserni G. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up. J Clin Pathol 52 (1999) 922-924
31. Dowlatshahi K., Fan M., Snider H.C., and Habib F.A. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 80 (1997) 1188-1197